Want to see HK:1763 full AI Analyst Report?
China Isotope & Radiation Corp. (1763) Stock Statistics & Valuation Metrics
Total Valuation
China Isotope & Radiation Corp. has a market cap or net worth of HKD 3.76B. The enterprise value is HKD 9.93B.
- Market Cap
- HKD 3.76B
- Enterprise Value
- HKD 9.93B
Share Statistics
China Isotope & Radiation Corp. has 79,968,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 79,968,800
- Owned by Insiders
- ―
- Owned by Institutions
- 2.12%
Financial Efficiency
China Isotope & Radiation Corp.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.34%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 5.34%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 1.92M
- Profits Per Employee
- 87.26K
- Employee Count
- 3,655
- Asset Turnover
- 0.45
- Inventory Turnover
- 2.58
Valuation Ratios
The current PE Ratio of China Isotope & Radiation Corp. is 10.36. China Isotope & Radiation Corp.’s PEG ratio is -0.37.
- PE Ratio
- 10.36
- PS Ratio
- 0.45
- PB Ratio
- 0.60
- Price to FCF
- 13.12
- Price to Operating Cash Flow
- 3.85
- PEG Ratio
- -0.37
Income Statement
In the last 12 months, China Isotope & Radiation Corp. had revenue of 7.00B and earned 318.95M in profits. Earnings per share was 1.00.
- Revenue
- 7.00B
- Gross Profit
- 3.52B
- Operating Income
- 916.20M
- Pretax Income
- 978.14M
- Net Income
- 318.95M
- EBITDA
- 1.18B
- Earnings Per Share (EPS)
- 1.00
Cash Flow
In the last 12 months, operating cash flow was 826.76M and capital expenditures -584.34M, giving a free cash flow of 242.42M billion.
- Operating Cash Flow
- 826.76M
- Free Cash Flow
- 242.42M
- Free Cash Flow per Share
- 0.76
Dividends & Yields
China Isotope & Radiation Corp. pays an annual dividend of HKD 0.09, resulting in a dividend yield of 4.20%
- Dividend Per Share
- HKD 0.09
- Dividend Yield
- 4.20%
- Payout Ratio
- 29.74%
- Free Cash Flow Yield
- 7.62%
- Earnings Yield
- 9.62%
Stock Price Statistics
- Beta
- 0.70
- 52-Week Price Change
- -38.60%
- 50-Day Moving Average
- 13.72
- 200-Day Moving Average
- 17.40
- Relative Strength Index (RSI)
- 36.64
- Average Volume (3m)
- 101.02K
Important Dates
China Isotope & Radiation Corp. upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- Oct 21, 2025
Financial Position
China Isotope & Radiation Corp. as a current ratio of 1.76, with Debt / Equity ratio of 52.15%
- Current Ratio
- 1.76
- Quick Ratio
- 1.51
- Debt to Market Cap
- 0.46
- Net Debt to EBITDA
- 0.11
- Interest Coverage Ratio
- 13.24
Taxes
In the past 12 months, China Isotope & Radiation Corp. has paid 330.79M in taxes.
- Income Tax
- 330.79M
- Effective Tax Rate
- 0.34
Enterprise Valuation
China Isotope & Radiation Corp. EV to EBITDA ratio is 2.85, with an EV/FCF ratio of 14.40.
- EV to Sales
- 0.49
- EV to EBITDA
- 2.85
- EV to Free Cash Flow
- 14.40
- EV to Operating Cash Flow
- 4.22
Balance Sheet
China Isotope & Radiation Corp. has HKD 2.55B in cash and marketable securities with HKD 2.86B in debt, giving a net cash position of -HKD 310.03M billion.
- Cash & Marketable Securities
- HKD 2.55B
- Total Debt
- HKD 2.86B
- Net Cash
- -HKD 310.03M
- Net Cash Per Share
- -HKD 3.88
- Tangible Book Value Per Share
- HKD 23.20
Margins
Gross margin is 49.52%, with operating margin of 12.92%, and net profit margin of 4.29%.
- Gross Margin
- 49.52%
- Operating Margin
- 12.92%
- Pretax Margin
- 14.14%
- Net Profit Margin
- 4.29%
- EBITDA Margin
- 17.16%
- EBIT Margin
- 13.21%
Analyst Forecast
The average price target for China Isotope & Radiation Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -4.92%
- EPS Growth Forecast
- -19.51%
Scores
- Smart Score
- 4
- AI Score
- 56